INMOBI
31.3.2021 06:02:09 CEST | Business Wire | Press release
InMobi, the world’s leading independent marketing cloud, has been recognized by the MMA SMARTIES MENA 2020, receiving 15 awards across a number of categories, acknowledging impactful campaigns with leading consumer brands. The MMA SMARTIES MENA Awards jury consisted of marketing thought leaders from MENA who voted on MMA MENA SMARTIES 2020’s winning campaigns after a thorough evaluation process of more than a hundred submissions.
In addition to the 13 listed below, InMobi won two of the association’s most coveted awards. For the second year running, the mobile industry leader was named Tech Enabler of the Year. And for the first time, it received the SMARTIES MENA 2020 Best-in-Show award for a Mars Snickers campaign it conducted in collaboration with Mediacom UAE and Xaxis UAE.
“2020 was a year unlike anything any of us have ever experienced before, featuring unique challenges that drove us to innovate on new solutions, dig deep into our creative reserves and forge still tighter bonds with our clients,” said Andy Powell, VP and Managing Director, EMEA at InMobi. “It's quite rewarding to see our close collaboration with agency partners, innovative spirit and creativity be acknowledged by the MMA. We thank the judges and salute the inspiring competition from other brands, agencies and technology providers across the region.”
InMobi also received awards in the following 13 categories:
- Location Based Services or Targeting: Hajj Pack Campaign for Hajj Pack / LifeBuoy / Unilever, Magna, Blis, DMS – GOLD
- Innovation: Axe Chill Campaign for Axe / Unilever, Magna, Anghami – GOLD
- Innovation: Snickers Hunger Support Campaign for Snickers / Mars, Mediacom UAE and Xaxis UAE – GOLD
- Machine Learning and AI: Snickers Hunger Support Campaign for Snickers / Mars, Mediacom UAE and Xaxis UAE – GOLD
- Brand Awareness: Vodafone Qatar 5G Launch Campaign – Red Velvet and Stop the Clock for Vodafone Qatar, Wavemaker Qatar – SILVER
- Product/Services Launch: Vodafone Qatar 5G Launch Campaign – Red Velvet and Stop the Clock for Vodafone Qatar, Wavemaker Qatar – SILVER
- COVID-19 Campaign of the Year: stc pay Stay at Home Campaign for stc pay, UM Saudi Arabia – SILVER
- Customer Experience: Snickers Hunger Support Campaign for Snickers / Mars, Mediacom UAE and Xaxis UAE - SILVER
- Data and Insights: Hajj Pack Campaign for Hajj Pack / LifeBuoy / Unilever, Magna, Blis, DMS – SILVER
- Data and Insights: Axe Chill Campaign for Axe / Unilever, Magna, Anghami – BRONZE
- Lead Gen/Direct Responses/Conversions: stc pay Stay at Home Campaign for stc pay, UM Saudi Arabia – BRONZE
- Mobile App: stc pay Stay at Home Campaign for stc pay, UM Saudi Arabia – BRONZE
- mCommerce: stc pay Stay at Home Campaign for stc pay, UM Saudi Arabia – BRONZE
For a full list of MMA SMARTIES MENA 2020 winners, please visit: https://www.mmamena.org/post/mmasmartiesmena2020winners
About InMobi
InMobi drives real connections between brands and consumers by leveraging its technology platforms and exclusive access to mobile intelligence. Its Marketing Cloud creates new paths for brands to understand, identify, engage and acquire connected consumers. As a leading technology company, InMobi has been recognized on both the 2018 and 2019 CNBC Disruptor 50 lists and as one of Fast Company’s 2018 World’s Most Innovative Companies. For more information, visit inmobi.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210330006130/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom